{{Rsnum
|rsid=2769605
|Chromosome=9
|position=85297756
|Orientation=minus
|GMAF=0.3577
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.4 | 55.0 | 12.6
| HCB | 4.4 | 27.7 | 67.9
| JPT | 0.9 | 23.2 | 75.9
| YRI | 4.1 | 21.8 | 74.1
| ASW | 3.5 | 35.1 | 61.4
| CHB | 4.4 | 27.7 | 67.9
| CHD | 4.6 | 27.8 | 67.6
| GIH | 45.0 | 42.0 | 13.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 17.2 | 48.3 | 34.5
| MKK | 4.5 | 34.0 | 61.5
| TSI | 42.6 | 44.6 | 12.9
| HapMapRevision=28
}}{{PMID|19488044|OA=1
}} Associated with [[bipolar disorder]] in individuals of African ancestry.

{{PMID Auto
|PMID=23137999
|Title=The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.
|OA=1
}}

{{PMID Auto
|PMID=23315174
|Title=Neurotrophic tyrosine kinase receptor type 2 (NTRK2) gene associated with treatment response to mood stabilizers in patients with bipolar I disorder.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}